Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Hoffmann

Showing results (231-240 of 253) with videos related to

Pageof 26
Sort By:
BMC Biotechnology|October 7, 2011
Design and development of a peptide-based adiponectin receptor agonist for cancer treatmentLaszlo Otvos, Eva Haspinger, Francesca La Russa, et al.
BMJ Health & Care Informatics|August 3, 2022
Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer careErik Ronmark, Ralf Hoffmann, Viktor Skokic, et al.
Pathogens (Basel, Switzerland)|December 23, 2022
Evaluation of S- and M-Proteins Expressed in <i>Escherichia coli</i> and HEK Cells for Serological Detection of Antibodies in Response to SARS-CoV-2 Infections and mRNA-Based VaccinationsMandy Schwarze, Ji Luo, Alexandra Brakel, et al.
Communications Biology|January 30, 2021
Glacial melt disturbance shifts community metabolism of an Antarctic seafloor ecosystem from net autotrophy to heterotrophyUlrike Braeckman, Francesca Pasotti, Ralf Hoffmann, et al.
Frontiers in Chemistry|November 5, 2014
Development of second generation peptides modulating cellular adiponectin receptor responsesLaszlo Otvos, Daniel Knappe, Ralf Hoffmann, et al.
Oncotarget|September 30, 2016
Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastasesRené Böttcher, Kalyan Dulla, Dianne van Strijp, et al.
Biochimica Et Biophysica Acta|June 17, 2008
Development of a pharmacologically improved peptide agonist of the leptin receptorLaszlo Otvos, Marianna Terrasi, Sandra Cascio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding proteinAnja Kunert, Josephine Losse, Christin Gruszin, et al.
Nature Communications|May 10, 2024
Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88Simon M Lauer, Maren Reepmeyer, Ole Berendes, et al.
Molecular Cancer Research : MCR|December 31, 2014
Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancerHélène Bon, Karan Wadhwa, Alexander Schreiner, et al.
Pageof 26

Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
BMC Biotechnology|October 7, 2011
Design and development of a peptide-based adiponectin receptor agonist for cancer treatmentLaszlo Otvos, Eva Haspinger, Francesca La Russa, et al.
BMJ Health & Care Informatics|August 3, 2022
Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer careErik Ronmark, Ralf Hoffmann, Viktor Skokic, et al.
Pathogens (Basel, Switzerland)|December 23, 2022
Evaluation of S- and M-Proteins Expressed in <i>Escherichia coli</i> and HEK Cells for Serological Detection of Antibodies in Response to SARS-CoV-2 Infections and mRNA-Based VaccinationsMandy Schwarze, Ji Luo, Alexandra Brakel, et al.
Communications Biology|January 30, 2021
Glacial melt disturbance shifts community metabolism of an Antarctic seafloor ecosystem from net autotrophy to heterotrophyUlrike Braeckman, Francesca Pasotti, Ralf Hoffmann, et al.
Frontiers in Chemistry|November 5, 2014
Development of second generation peptides modulating cellular adiponectin receptor responsesLaszlo Otvos, Daniel Knappe, Ralf Hoffmann, et al.
Oncotarget|September 30, 2016
Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastasesRené Böttcher, Kalyan Dulla, Dianne van Strijp, et al.
Biochimica Et Biophysica Acta|June 17, 2008
Development of a pharmacologically improved peptide agonist of the leptin receptorLaszlo Otvos, Marianna Terrasi, Sandra Cascio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding proteinAnja Kunert, Josephine Losse, Christin Gruszin, et al.
Nature Communications|May 10, 2024
Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88Simon M Lauer, Maren Reepmeyer, Ole Berendes, et al.
Molecular Cancer Research : MCR|December 31, 2014
Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancerHélène Bon, Karan Wadhwa, Alexander Schreiner, et al.
Pageof 26